LOGIN  |  REGISTER
Chimerix
Recursion

WELL Health Technologies to Present at the 2024 Cantech Letter Conference in Toronto, ON

October 01, 2024 | Last Trade: C$4.66 0.15 3.33

Vancouver, British Columbia and Toronto, Ontario--(Newsfile Corp. - October 1, 2024) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ("WELL" or the "Company"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce its participation at the upcoming Cantech Letter Investment Conference on Wednesday, October 9, 2024, in Toronto Ontario. Hamed Shahbazi, Founder and CEO of WELL will be doing an investor presentation and participating in 1-on-1 meetings with investors at the conference. Mr. Shahbazi will also be participating on a panel titled "Growth Through Acquisition in the Canadian Capital Markets" at 12:30pm.

2024 Cantech Letter Conference

Date: Wednesday, October 9, 2024

Location: Arcadian Loft, 8th floor, 401 Bay Street, Toronto, ON

Contact: This email address is being protected from spambots. You need JavaScript enabled to view it. to register

More info: https://www.cantechletter.com/conference/

About Cantech Letter Conference

The Cantech Letter Conference, recognized as Canada's foremost technology investment event, provides up and coming technology companies with the unique opportunity to showcase their innovations and growth strategies, and participate in individual 1-on-1 meetings with potential investors and capital markets professionals. The conference serves as a hub for networking, knowledge exchange, and investment opportunities, while also featuring panel discussions with industry experts to offer insights into current trends, challenges, and opportunities within the technology sector.

About WELL Health Technologies Corp.

WELL's mission is to tech-enable healthcare providers. We do this by developing the best technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. WELL's comprehensive healthcare and digital platform includes extensive front and back-office management software applications that help physicians run and secure their practices. WELL's solutions enable more than 37,000 healthcare providers between the US and Canada and power the largest owned and operated healthcare ecosystem in Canada with more than 180 clinics supporting primary care, specialized care, and diagnostic services. In the United States WELL's solutions are focused on specialized markets such as the gastrointestinal market, women's health, primary care, and mental health. WELL is publicly traded on the Toronto Stock Exchange under the symbol "WELL" and on the OTC Exchange under the symbol "WHTCF". To learn more about WELL, please visit: www.well.company. 

For additional Information:

Tyler Baba

Investor Relations, Manager

WELL Health Technologies

This email address is being protected from spambots. You need JavaScript enabled to view it.

604-628-7266

Astria Therapeutics

Stock Quote

Featured Stock

Astria Therapeutics

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...

CLICK TO LEARN MORE

Featured Stock

Immix Biopharma

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB